Related Experiment Video
Updated: Aug 7, 2026

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts
Published on: July 27, 2015
Reperfusion in acute myocardial infarction: current concepts
Demosthenes Katritsis1, Evangelia Karvouni, Michael M Webb-Peploe
1Department of Cardiology, Athens Euroclinic, Athens, Greece. dkatrits@otenet.gr
Insights
Primary angioplasty with stenting offers superior outcomes for acute myocardial infarction compared to thrombolysis alone. Facilitated angioplasty shows promise, with ongoing trials evaluating its efficacy and safety.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Myocardial reperfusion is crucial for treating acute myocardial infarction (AMI).
- Pharmacological thrombolysis achieves coronary artery patency in approximately two-thirds of AMI patients.
- Mechanical reperfusion via primary angioplasty and stenting demonstrates higher patency rates and fewer complications, particularly in high-risk individuals.
Purpose of the Study:
- To compare the effectiveness of different reperfusion strategies in acute myocardial infarction.
- To evaluate the potential of facilitated angioplasty as a treatment for AMI.
Main Methods:
- Review of current treatment options for myocardial reperfusion.
- Discussion of adjunctive pharmacotherapy and device technology in primary angioplasty.
- Exploration of facilitated angioplasty protocols including thrombolysis and glycoprotein IIb/IIIa inhibitors.
Main Results:
- Primary angioplasty and stenting yield higher coronary artery patency rates than thrombolysis.
- Mechanical reperfusion is associated with fewer complications, especially in high-risk AMI patients.
- Facilitated angioplasty represents a promising strategy currently under investigation.
Conclusions:
- Mechanical reperfusion, particularly primary angioplasty and stenting, is the preferred treatment for acute myocardial infarction.
- Adjunctive therapies and novel devices may further enhance primary angioplasty outcomes.
- Facilitated angioplasty warrants further evaluation in ongoing clinical trials for AMI management.
Abstract:
Myocardial reperfusion is the treatment of choice in acute myocardial infarction. Pharmacological thrombolysis restores coronary artery patency in about two thirds of patients with acute myocardial infarction. However, mechanical reperfusion with primary angioplasty and stenting achieves higher patency rates with less complications, especially in high-risk patients. Adjunctive pharmacotherapy and new device technology may improve the outcome of primary angioplasty. Facilitated angioplasty using a combination of half-dose thrombolysis, platelet glycoprotein IIb/IIIa antagonists, and early intervention, appears to be a promising strategy for the treatment of acute myocardial infarction in the modern era. The efficacy and safety of this approach are currently evaluated in several ongoing trials.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Stroke ll: Pathophysiology

